Cyclosporine Downregulates Fas Ligand Expression on Vascular Endothelial Cells: Implication for Accelerated Vasculopathy by Immunosuppressive Therapy
- 24 September 1999
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 263 (2) , 430-432
- https://doi.org/10.1006/bbrc.1999.1392
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Cyclosporine induces cancer progression by a cell-autonomous mechanismNature, 1999
- Negative Regulation of Inflammation by Fas Ligand Expression on the Vascular EndotheliumTrends in Cardiovascular Medicine, 1999
- Is extravasation a Fas-regulated process?Molecular Medicine Today, 1999
- TNFα regulation of Fas ligand expression on the vascular endothelium modulates leukocyte extravasationNature Medicine, 1998
- The Fas Death FactorScience, 1995
- Effects of cyclosporin, FK506, and rapamycin on graft-vessel diseaseThe Lancet, 1991
- RAPAMYCIN FOR IMMUNOSUPPRESSION IN ORGAN ALLOGRAFTINGThe Lancet, 1989
- CANCERS FOLLOWING CYCLOSPORINS THERAPYTransplantation, 1987
- Cyclosporine-associated renal arteriopathy resulting in loss of allograft functionThe American Journal of Surgery, 1985
- Culture of Human Endothelial Cells Derived from Umbilical Veins. IDENTIFICATION BY MORPHOLOGIC AND IMMUNOLOGIC CRITERIAJournal of Clinical Investigation, 1973